#managed access program in india

[earlyaccessprograms]

Named Patient Program on about.me

I am a therapist, psychologist, and public speaker in noida. Visit my website.

[earlyaccessprograms]

A Global Named Patient Program

Understanding Named Patient Programs: How They Work, Benefits, and Challenges

When a patient suffers from a serious or rare disease, and the required medicine is not available in their country, the situation feels helpless. In such cases, a legal, defined route exists, called a Named Patient Program in India.

What Is a Named Patient Program?

A Named Patient Program (NPP) is a regulatory mechanism in which physicians can make a request to provide access to medicines that are not registered or commercially available in a country to an individual, named patient. This does not fall under a clinical trial. It is not an illicit procurement. It is a structured, doctor-initiated process that operates within the boundaries of the local health regulations.

In India, this is regulated through the Drugs and Cosmetics Act and allows the licensed importers and the healthcare professionals to clear the unapproved medicines in India for the defined patients with an established medical need.

How Does It Actually Work?

The process generally begins with a treating physician. The physician orders a particular medicine that is not available in the Indian market. After that, the physician would submit a request through a licensed Patient Access Program in India, which could be a company like Ikris Pharma Network, who would then take care of all the regulatory paperwork, medical sourcing, import clearance, and the cold-chain logistics.

A reliable Global Named Patient Supplier sources medicines from the original manufacturer or an authorized distributor, ensuring the authenticity, safety, and compliance at all stages. The medicines are imported legally, and provided to the patients or hospitals, under the supervision of medical professionals.

Benefits That Matter Most

For patients suffering from rare cancers or other serious illnesses like rare neurological disorders or complications from transplantation, NPPs can be life-saving. Access is the most important benefit as patients do not need to wait several years for an NPP to undergo the Indian drug approval process. NPPs that are managed by the Unapproved Medicine Access India specialists ensure that the quality and safety are not compromised.

Physicians benefit as well, as they can offer their patients treatment options that are available and used across the globe while fully complying with the Indian regulations.

Common Challenges

NPPs are complex. Costs can be significant, are mainly dependent on the drug and the country where it is manufactured. Not every medicine qualifies and is evaluated on a case-by-case basis.

This is where an experienced partner becomes invaluable. Ikris Pharma Networks Limited's Named Patient Management services were designed to solve this problem by handling compliance, pharmacovigilance, the protection of patient data, and global sourcing.

Is This Beneficial for Your Patient?

If you are a doctor or a caregiver looking for options for a patient needing a medicine that is not available in India, reaching out to a specific Named Patient Program in India is the right place to start. There is legal access to life-saving medicines and it all begins with the right conversation.

[earlyaccessprograms]

Named Patient Management: The Ability for Patients in India to Access Unapproved Essential Medicines

Patients in India with an illness, disease, or any condition for which there is no treatment or approved medication in India, may not have the luxury of waiting for a medication to be approved and launched in India. For these patients, the Named Patient Program in India may be their saving grace.

Named Patient Management, or how Named Patient Management is defined, is a legal, organized way to provide individual patients in India with access to medications that are not yet available or approved for sale in India. Often referred to as Managed or Early Access Programs, Named Patient Management allows patients to acquire drugs or medicines that are still investigational or approved internationally, but have yet to be launched in India.

What some may refer to as Named Patient Supply, is a fully legal way to obtain medication that is provided through real and legal channels. It requires obtaining access from India’s central drug authority, CDSCO, along with proper documents from the patient’s oncologist or doctor, and working with licensed Global Named Patient Suppliers who assist with the drug importation and delivery, as well as the management of the actual delivery.

Who is This For

Named Patient Supply is a great option for patients with a need for oncology medicines, rare disease treatments, and any other medication that is not available in India. If a doctor in India wants to prescribe a medication that is approved in other parts of the world, but not yet approved in India, and an import license is not obtained, the Named Patient Program is the best, and perhaps the only, option for that patient.

Our Journey Explained

Usually, compassionate use requests are submitted by the doctor of the patient. It is then sent to the approval of the CDSCO. A certified Named Patient Program importer will then legally and safely take care of importing the medicine to India.

Having knowledgeable suppliers will ensure that the medicine will arrive at the right place at the right time and that no one will face a customs related legal issue. You and your family will have the quality of life you need, and the peace of mind you deserve during a very difficult period.

Legal, Reliable, and Patient-Focused

If you are looking for legal access to unapproved medicines in India or need guidance on the Expanded Access Program, choosing the right supplier makes all the difference. Work with someone who truly understands the process, communicates clearly, and always keeps the patient's wellbeing at the heart of what they do. That is not just good service — that is the standard every patient deserves.

[ikrishealthplus]

The Impact of Mobile Apps on Patient Engagement in Healthcare

In the rapidly evolving landscape of healthcare, the integration of mobile apps has revolutionized patient engagement. Mobile apps have become powerful tools that not only enhance communication between patients and healthcare providers but also empower individuals to take charge of their health and well-being. The impact of mobile apps on patient engagement in healthcare is profound and multifaceted, leading to improved outcomes, increased efficiency, and a more personalized approach to healthcare delivery. Furthermore, for pharma distributors, apps like iKris Health + offer unprecedented opportunities for streamlining operations, optimizing supply chains, and enhancing customer relationships.

Enhancing Communication and Accessibility Mobile apps have bridged the gap between patients and healthcare providers, enabling seamless communication and access to medical information. Patients can easily schedule appointments, receive medication reminders, access test results, and communicate with their healthcare team in real-time. This enhanced accessibility fosters a sense of empowerment and involvement in one's healthcare journey, leading to better adherence to treatment plans and improved health outcomes.

Empowering Patients through Education and Monitoring Mobile apps offer a wealth of resources and tools that empower patients to make informed decisions about their health. From educational materials on specific conditions to personalized wellness tips, mobile apps provide valuable information that promotes health literacy and encourages proactive health management. Additionally, apps that allow patients to track their symptoms, monitor vital signs, and record medication adherence enable individuals to actively participate in their care actively, leading to better self-management and overall health improvement.

Personalizing Healthcare Delivery and Improving Outcomes By leveraging data collected through mobile apps, healthcare providers can gain valuable insights into patient behavior, preferences, and health status. This data-driven approach enables personalized care plans tailored to individual needs, preferences, and goals. Through remote monitoring and telehealth services facilitated by mobile apps, healthcare providers can offer timely interventions, preventive care, and continuous support, ultimately leading to improved outcomes and patient satisfaction.

Ikris Health+ is poised to transform the accessibility of rare medications with its innovative features. Users can effortlessly explore a vast database to locate medicines unavailable locally. The platform also provides transparency on medication costs and educates users on their country's regulations regarding unregistered drugs. Furthermore, the app offers swift support through a simple inquiry submission process. This initiative reflects Ikris Pharma Network's commitment to enhancing global healthcare access by facilitating the procurement of essential medications despite geographical and regulatory challenges. You can install this application as Ikris Health Plus Apps on Google Play is available.

The impact of mobile apps on patient engagement in healthcare is transformative, empowering individuals to become active participants in their health journey. By enhancing communication, providing education and monitoring tools, and personalizing healthcare delivery, mobile apps have revolutionized the way patients interact with the healthcare system. As technology continues to advance, the potential for mobile apps to further improve patient engagement and outcomes in healthcare is limitless.

References: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029126/ https://www.annualreviews.org/content/journals/10.1146/annurev-publhealth-052020-103738